Aryl hydrocarbon (Ah) nonresponsiveness in estrogen receptor-negative MdA-MB-231 cells is associated with expression of a variant Arnt protein

Archives of Biochemistry and Biophysics

Volumn 346, Issue 1, 1997, Pages 65-73

  Wilson, Cody L ^a   Thomsen, Jane ^a   Hoivik, Debie J ^a   Wormke, Mark T ^a   Stanker, Larry ^b   Holtzapple, Carol ^b   Safe, Stephen H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b SOUTHERN PLAINS AGRICULTURAL RESEARCH CENTER   (United States)

Author keywords

ER negative; Human breast cancer cells; Variant Arnt

Indexed keywords

AROMATIC HYDROCARBON; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031260094     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1997.0289     Document Type: Article

References (49)

1. Muss H. B. Breast Cancer Res. Treat. 21:1992;15-26.
2. Santen R. J., Manni A., Harvey H., Redmond C. Endocr. Rev. 11:1990;221-265.
3. Clarke R., Skaar T., Baumann K., Leonessa F., James M., Lippman J., Thompson E. W., Freter C., Brunner N. Breast Cancer Res. Treat. 31:1994;237-248.
4. Ethier S. P. J. Natl. Cancer Inst. 87:1995;964-973.
5. Dickson R. B., Lippman M. E. Endocr. Rev. 16:1995;559-589.
6. Clark G., Osborne C., McGuire W. J. Clin. Oncol. 2:1984;1102-1109.
7. Osborne C. K., Yochmowitz M. G., Knight W. A. I., McGuire W. L. Cancer. 12:1980;2884-2888.
8. Dickson R. B., Lippman M. E. Endocr. Rev. 8:1987;29-43.
9. Dickson R. B., Lippman M. E. Cancer Surv. 5:1986;617-624.
10. Clarke R., Brunner N., Katzenellenbogen B. S., Thompson E. W., Norman M. J., Koppi C., Paik S., Lippman M. E., Dickson R. B. Proc. Natl. Acad. Sci. USA. 86:1989;3649-3653.
11. Wakeling A. E., Newboult E., Peters S. W. J. Mol. Endocrinol. 2:1989;225-234.
12. Soule H. D., McGrath C. M. Cancer Lett. 10:1980;177-189.
13. Jordan V. C., Gottardis M. M., Robinson M. P., Friedl A. J. Steroid Biochem. 34:1989;169-176.
14. Osborne C. K., Hobbs K., Clark G. M. Cancer Res. 45:1985;584-590.
15. Vickers P. J., Dufresne M. J., Cowan K. H. Mol. Endocrinol. 3:1989;157-164.
16. Thomsen J. S., Nissen L., Stacey S. N., Hines R. N., Autrup H. Eur. J. Biochem. 197:1991;577-582.
17. Thomsen J. S., Wang X., Hines R. N., Safe S. Carcinogenesis. 15:1994;933-937.
18. Wang X., Thomsen J. S., Santostefano M., Rosengren R., Safe S., Perdew G. H. Eur. J. Pharmacol. 293:1995;191-205.
19. Harris M., Piskorska-Pliszczynska J., Zacharewski T., Romkes M., Safe S. Cancer Res. 49:1989;4531-4535.
20. Jaiswal A. K., Nebert D. W., Eisen H. J. Biochem. Pharmacol. 34:1985;2721-2731.
21. Pasanen M., Stacey S., Lykkesfeldt A., Briand P., Hines R., Autrup H. Chem.-Biol. Interact. 66:1988;223-232.
22. Wang W. L., Thomsen J. S., Porter W., Moore M., Safe S. Br. J. Cancer. 73:1996;316-322.
23. Whitlock J. P. Jr. Chem. Res. Toxicol. 6:1993;754-763.
24. Swanson H. I., Bradfield C. A. Pharmacogenetics. 3:1993;213-223.
25. Burbach K. M., Poland A. B., Bradfield C. A. Proc. Natl. Acad. Sci. USA. 89:1992;8185-8189.
26. Ema M., Sogawa K., Watanabe N., Chujoh Y., Matsushita N., Gotoh O., Funae Y., Fujii-Kuriyama Y. Biochem. Biophys. Res. Commun. 184:1992;246-253.
27. Hoffman E. C., Reyes H., Chu F., Sander F., Conley L. H., Brooks B. A., Hankinson O. Science. 252:1991;954-958.
28. Piskorska-Pliszczynska J., Safe S. Arch. Biochem. Biophys. 267:1988;372-383.
29. Omiecinski C. J., Redlich C. A., Costa P. Cancer Res. 50:1990;4315-4321.
30. Sutter T. R., Tang Y. M., Hayes C. L., Wo Y. P., Jabs E. W., Li X., Yin H., Cody C. W., Greenlee W. F. J. Biol. Chem. 269:1994;13092-13099.
31. Döhr O., Vogel C., Abel J. Arch. Biochem. Biophys. 321:1995;405-412.
32. Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 187-210.
33. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. J. Mol. Biol. 215:1990;403-410.
34. Watts C. K., Brady A., Sarcevic B., deFazio A., Musgrove E. A., Sutherland R. L. Mol. Endocrinol. 9:1995;1804-1813.
35. Bradford M. M. Anal. Biochem. 72:1976;248-254.
36. Perdew G. H., Abbott B., Stanker L. H. Hybridoma. 14:1995;279-283.
37. Hord N. G., Perdew G. H. Mol. Pharmacol. 46:1994;618-626.
38. Laemmli U. Nature. 227:1970;680-685.
39. Denison M. S., Deal R. M. Mol. Cell. Endocrinol. 69:1990;51-57.
40. Huggett R. J., Bender M. E., Unger M. A. Fate and Effects of Sediment-Bound Chemicals in Aquatic Systems. 1987;Pergamon Press, Oxford. p. 327-341.
41. Mount S. M. Nucleic Acids Res. 10:1982;459-472.
42. Solovyev V. V., Salamov A. A., Lawrence C. B. Nucleic Acids Res. 22:1994;5156-5163.
43. Whitelaw M. L., Gustafsson J., Poellinger L. Mol. Cell. Biol. 14:1994;8343-8355.
44. Jain S., Dolwick K. M., Schmidt J. V., Bradfield C. A. J. Biol. Chem. 269:1994;31518-31524.
45. Corton J. C., Moreno E. S., Hovis S. M., Leonard L. S., Gaido K. W., Joyce M. M., Kennett S. B. Toxicol. Appl. Pharmacol. 139:1996;272-280.
46. Wang W., Porter W., Burghardt R., Safe S. Carcinogenesis. 18:1997;925-933.
47. Thompson E. W., Paik S., Brunner N., Sommers C. L., Zugmaier G., Clarke R., Shima T. B., Torri J., Donahue S., Lippman M. E. J. Cell Physiol. 150:1992;534-544.
48. Bae S., Arand G., Azzam H., Pavasant P., Torri J., Frandsen T. L., Thompson E. W. Breast Cancer Res. Treat. 24:1993;241-255.
49. Sommers C. L., Walker-Jones D., Heckford S. E., Worland P., Valverius E., Clark R., McCormick F., Stampfer M., Abularach S., Gelmann E. P. Cancer Res. 49:1989;4258-4263.